• Twitter
  • Jobs
ProCURE oncology
  • HOME
  • ABOUT US
  • RESEARCH GROUP
    • Molleví’s Lab
    • Antolin’s Lab
    • Alemany’s & Piulats’s lab
    • Martínez-Balibrea’s Lab
    • Aytes’s Lab
    • Belver’s Lab
    • Pujana’s Lab
    • Menendez’s Lab
    • Sureda’s & Farre’s Lab
    • Casanovas’s Lab
    • Viñals’s lab
  • INNOVATION
  • NEWS
  • CONTACT
  • Menu Menu

Patient-Derived Models of Prostate Cancer: Capturing Tumour Complexity from Initiation to Metastasis

19 de August de 2026
Cancer Lett. 2026 Aug 19:218791. doi: 10.1016/j.canlet.2026.218791.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 2026-08-19 10:00:002026-08-19 10:00:00Patient-Derived Models of Prostate Cancer: Capturing Tumour Complexity from Initiation to Metastasis

Recent Advances in Understanding the Biology of Castration-Resistant Prostate Cancer

15 de April de 2026
Urol Clin North Am. 2026 May;53(2):303-315. doi: 10.1016/j.ucl.2026.02.012.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 2026-04-15 10:00:002026-04-15 10:00:00Recent Advances in Understanding the Biology of Castration-Resistant Prostate Cancer

A rise in double-strand breaks sensitizes tumors to oxidative metabolism inhibitors

11 de March de 2026
Biomed Pharmacother. 2026 Mar 10;197:119184. doi: 10.1016/j.biopha.2026.119184.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 2026-03-11 10:00:002026-03-11 10:00:00A rise in double-strand breaks sensitizes tumors to oxidative metabolism inhibitors

Harnessing transcriptional regulation of alternative end-joining to predict cancer treatment

10 de March de 2025
NAR Cancer. 2025 Mar 7;7(1):zcaf007. doi: 10.1093/narcan/zcaf007.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 2025-03-10 10:00:002025-03-10 10:00:00Harnessing transcriptional regulation of alternative end-joining to predict cancer treatment

Identification of differential biological activity and synergy between the PARP inhibitor rucaparib and its major metabolite

9 de February de 2024
Cell Chem Biol. 2024 Feb 6:S2451-9456(24)00043-6. doi: 10.1016/j.chembiol.2024.01.007.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 2024-02-09 11:00:002024-02-09 11:00:00Identification of differential biological activity and synergy between the PARP inhibitor rucaparib and its major metabolite

Editor’s Note: Dual Targeting of the Akt/mTOR Signaling Pathway Inhibits Castration-Resistant Prostate Cancer in a Genetically Engineered Mouse Model

4 de April de 2023
Cancer Res. 2023 Apr 4;83(7):1160. doi: 10.1158/0008-5472.CAN-23-0516.NO…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2023-04-04 10:00:002023-04-04 10:00:00Editor’s Note: Dual Targeting of the Akt/mTOR Signaling Pathway Inhibits Castration-Resistant Prostate Cancer in a Genetically Engineered Mouse Model

A hotspot for posttranslational modifications on the androgen receptor dimer interface drives pathology and anti-androgen resistance

15 de March de 2023
Sci Adv. 2023 Mar 17;9(11):eade2175. doi: 10.1126/sciadv.ade2175.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2023-03-15 10:00:002023-03-15 10:00:00A hotspot for posttranslational modifications on the androgen receptor dimer interface drives pathology and anti-androgen resistance

An Integrated Approach for the Early Detection of Endometrial and Ovarian Cancers (Screenwide Study): Rationale, Study Design and Pilot Study

27 de July de 2022
J Pers Med. 2022 Jun 29;12(7):1074. doi: 10.3390/jpm12071074.ABSTRACTScreenwide…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2022-07-27 10:00:002022-07-27 10:00:00An Integrated Approach for the Early Detection of Endometrial and Ovarian Cancers (Screenwide Study): Rationale, Study Design and Pilot Study

Chemotherapy in metastatic castration-resistant prostate cancer: Current scenario and future perspectives

13 de September de 2021
Cancer Lett. 2021 Dec 28;523:162-169. doi: 10.1016/j.canlet.2021.08.033.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2021-09-13 10:00:002021-09-13 10:00:00Chemotherapy in metastatic castration-resistant prostate cancer: Current scenario and future perspectives

A modular master regulator landscape controls cancer transcriptional identity

12 de January de 2021
Cell. 2021 Jan 21;184(2):334-351.e20. doi: 10.1016/j.cell.2020.11.045.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2021-01-12 11:00:002021-01-12 11:00:00A modular master regulator landscape controls cancer transcriptional identity

Taxane-induced Attenuation of the CXCR2/BCL-2 Axis Sensitizes Prostate Cancer to Platinum-based Treatment

6 de November de 2020
Eur Urol. 2021 Jun;79(6):722-733. doi: 10.1016/j.eururo.2020.10.001.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2020-11-06 11:00:002020-11-06 11:00:00Taxane-induced Attenuation of the CXCR2/BCL-2 Axis Sensitizes Prostate Cancer to Platinum-based Treatment

Sensitivity of cervico-vaginal cytology in endometrial carcinoma: A systematic review and meta-analysis

24 de March de 2020
Cancer Cytopathol. 2020 Nov;128(11):792-802. doi: 10.1002/cncy.22266.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2020-03-24 10:00:002020-03-24 10:00:00Sensitivity of cervico-vaginal cytology in endometrial carcinoma: A systematic review and meta-analysis
Page 1 of 3123

Filter by categories

  • Alemany’s & Piulats’s lab (133)
  • Antolin's lab (36)
  • Aytes's Lab (25)
  • Belver's Lab (25)
  • Casanovas's Lab (77)
  • Martínez-Balibrea's Lab (43)
  • Menendez's Lab (121)
  • Molleví's Lab (35)
  • Pujana's Lab (110)
  • Sin categoría (5)
  • Sureda's & Farre's Lab (281)
  • Viñals's lab (111)

Twitter

Tweets by ProcureICO
Program Against Cancer Therapeutic Resistance

CONTACT US

Campus IDIBELL
(L’Hospitalet del Llobregat)
Hospital Duran i Reynals, Gran Via 199,
L’Hospitalet del Llobregat,
Barcelona 08908
Tel. +34 93 260 7952

Campus IGTP-IJC
(Badalona)
Campus Can Ruti – IGTP – Building Muntanya,
Rd. Can Ruti, Camí de les escoles s/n,
Badalona, Barcelona 08916
Tel. +34 93 554 3069

Campus IDIBGI
(Girona)
Parc Hospitalari Martí i Julià de Salt, Dr. Castany s/n,
Salt, Girona 17190
Tel. +34 872 987 087

© Copyright - Edisenius
  • Privacy Policy
  • Cookie Policy
  • Legal Notice
Scroll to top
Manage cookie consent
To offer the best experiences, we use technologies such as cookies to store and/or access device information. Consent to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Failure to consent, or withdrawal of consent, may adversely affect certain features and functions.
Functional Always active
Storage or technical access is strictly necessary for the legitimate purpose of allowing the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. Storage or technical access that is used exclusively for anonymous statistical purposes. Without a requirement, voluntary compliance by your Internet service provider, or additional records from a third party, information stored or retrieved solely for this purpose cannot be used to identify you.
Marketing
Storage or technical access is necessary to create user profiles to send advertising, or to track the user on a website or several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
See preferences
{title} {title} {title}